Tirzepatide (Mounjaro's active ingredient) offers dual GLP-1 and GIP pathway activation, potentially enhancing weight loss beyond semaglutide alone
When compared with all control groups (including placebo, basal insulin, and GLP1-RA), our analysis did not show a statistically significant association between tirzepatide use and the incidence of cholelithiasis, cholecystitis, biliary diseases, or the the composite of gallbladder or biliary diseases, as shown in Supplementary Figure S6
While effective for diabetes and obesity, semaglutide may cause joint pain through inflammation, blood sugar changes, weight loss, and cartilage effects
500K people track their GLP-1 with MeAgain, the app has a 4.8-star App Store rating across 25K ratings and is available on iPhone and Android
Track Your Progress : Keeping a journal of your food intake, exercise habits, and medication schedule can help you identify patterns and make necessary adjustments
This type of loss follows specific patterns: receding hairline and crown thinning in men, widening part and diffuse thinning in women